About US
Contact us
-
Polyplus-transfection Licenses ZNA Oligonucleotide Technology to MetabionPolyplus-transfection SA, a company developing innovative solutions for molecular and cellular biology, recently announced that Metabion GmbH, a company specializing in custom synthesis of bio2010/3/12
-
Unilife & sanofi-aventis Agree to Exclusivity List for Unifill RTF SyringeUnilife Corporation recently announced it has agreed to a list of therapeutic drug classes within which sanofi-aventis has the exclusive right to purchase the Unifill ready-to-fill syringe. Sa2010/3/11
-
Pantec Biosolutions Successfully Delivers Largest Protein TransdermallyPantec Biosolutions AG, a privately owned company developing innovative transdermal drug delivery products, recently announced it has achieved excellent results in a Phase I clinical trial of2010/3/11
-
Merrion Pharmaceuticals Granted Pivotal US Patent on GIPET TechnologyUnderscoring the innovation leadership of its GIPET (Gastrointestinal Permeation Enhancement Technology) drug delivery technology, Merrion Pharmaceuticals plc, an international specialty pharm2010/3/11
-
Antares Completes Patient Enrollment in Phase III Pivotal Trial of AnturolAntares Pharma, Inc. recently announced it has completed enrollment in the double-blind portion of the company’s Phase III clinical trial of Anturol, its transdermal oxybutin ATD gel for the t2010/3/10
-
Mallinckrodt Baker Partners With Sotax to Promote Complete Dissolution Testing CapabilitiesCovidien, a leading global provider of healthcare products, recently announced a global alliance between its Mallinckrodt Baker performance chemicals business and the Sotax Group to promote J.2010/3/10
-
GAMP® Good Practice Guide: Manufacturing Execution Systems Guide Now AvailableISPE, a global not-for-profit association of 24,000 technical professionals working in the manufacturing and drug development sectors of the pharmaceutical industry, has released a new guidance docume2010/3/10
-
ISP to increase prices on 1,4 Butanediol and derivatives, including:Wayne, N.J. – March 1, 2010 – International Specialty Products Inc. (“ISP”) has announced a global price increase for 1,4 Butanediol and derivatives, including: N-Methyl-2-Pyrrolidone (NMP),2010/3/9
-
New Developments In Packaging Mark A Real Step Forward For The Pharmaceuticals SectorIMA Safe has recently developed a new medium-speed packaging line for topical drug products. Production began in 2009 and the new line is mainly intended for Japan. The Japanese market has the highest2010/3/9
-
IPEC-AMERICAS NEWSsource:web of IPEC20100309(1).part1.rar20100309(1).part2.rar20100309(1).part3.rar20100309(1).part4.rar20100309(1).part5.rar20100309(1).part6.rar2010/3/9